The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
Despite improvements in awareness and treatment of type II diabetes mellitus (TIIDM), this disease remains a major source of morbidity and mortality worldwide, and prevalence continues to rise. Oxidative damage caused by free radicals has long been known to contribute to the pathogenesis and progres...
Main Authors: | Joshua A. David, William J. Rifkin, Piul S. Rabbani, Daniel J. Ceradini |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2017/4826724 |
Similar Items
-
The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones
by: Matheus de Freitas Silva, et al.
Published: (2018-07-01) -
Keap1/Nrf2 Signaling Pathway
by: Gerasimos P. Sykiotis
Published: (2021-05-01) -
Inhibition of the Keap1/Nrf2 Signaling Pathway Significantly Promotes the Progression of Type 1 Diabetes Mellitus
by: Yanmei Lou, et al.
Published: (2021-01-01) -
Targeting the Nrf2/Keap1 interaction
by: Steel, Richard James
Published: (2014) -
Keap1âNrf2 pathway: A promising target towards lung cancer prevention and therapeutics
by: Ying-Hui Tong, et al.
Published: (2015-09-01)